Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis (ALPINE-SVG)

This study is ongoing, but not recruiting participants.
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Emmanouil Brilakis, North Texas Veterans Healthcare System Identifier:
First received: October 14, 2010
Last updated: April 16, 2015
Last verified: April 2015